BioWorld

Dec. 2, 2004

View Archived Issues

Clofarabine: Endorsed For Use In ALL, But Not AML

SILVER SPRING, Md. - The FDA's Oncologic Drugs Advisory Committee split its vote regarding clofarabine, ILEX Oncology Inc.'s cancer product. (BioWorld Today) Read More

FDA Committee United Against Marqibo's Accelerated Approval

Read More

Intarcia Raises $50M ViaSeries E For Atamestane

Read More

Sirtris Series A Garners $13M For Developing Class III HDACs

Read More

Other News To Note

Read More